Kidney Cancer

NSS Offers Better Renal Function Preservation

By

Compared with radical nephrectomy, nephron-sparing surgery shift serum creatinine downward.

Statins Improve Kidney Cancer Surgery Outcomes

By

Study demonstrates improved disease-specific and overall survival.

CKD Risk Factors in RCC Surgery Patients Identified

By

Male gender and older age found to be significantly associated with chronic kidney disease before and surgery.

Adjuvant Intravesical Chemotherapy Still Underused

By

Only 2% of patients receive it after transurethral resection of bladder tumors, despite guideline recommendations.

More Comorbidities Predict Greater PN Complication Risk

By

New findings have implications for preoperative patient counseling.

Metabolic Syndrome Predicts Complications After Radical Nephrectomy

By

Study finds a 1.6 times increased risk, but no association with complications after radical cystectomy or prostatectomy.

Racial Differences Found in Partial Nephrectomy Use

By

Hispanics are 20% less likely to undergo the procedure than whites.

Kidney Cancer Mortality Lower with Surgery

By

The harms of nephrectomy, however, need to be weighed against the marginal survival benefit for some patients.

Data Support Robot-Assisted Partial Nephrectomy for Kidney Cancer

By

Cancer-specific and the cancer-free survival rates were 99% at three and five years.

CKD Risk Higher with Radical Nephrectomy

By

Risk is threefold greater when compared with partial nephrectomy.

New Immunoassay May Enable Early Kidney Cancer Detection

By

A new immunoassay appears to be a valid screening method for the early detection of kidney cancer.

Percutaneous Cryoablation An Option for Renal Tumors

By

It is associated with a high technical success rate and a low rate of complications; local recurrence rare.

Renal Cryoablation Outcomes Durable

By

After a median follow-up of 36 months, 98% of patients had no recurrence of small renal tumors.

Partial Nephrectomy May Improve Survival

By

Partial nephrectomy may lead to better overall survival and fewer health problems after surgery in patients with kidney tumors.

Metastases to the Kidney May Be Mistaken for Primary Tumors

By

Communication between the urologist and pathologist is key to arriving at the correct diagnosis, researcher says.

Weight Loss, Muscle Depletion May Predict Cancer Survival

Weight Loss, Muscle Depletion May Predict Cancer Survival

Regardless of overall body weight, patients with these additional criteria share a poor prognosis.

Point & Counterpoint: radical vs. partial nephrectomy

Two respected doctors share their thoughts on the preferred method of kidney cancer treatment.

High BMI, Visceral Obesity May Benefit Kidney Cancer Patients

By

For patients with metastatic disease receiving systemic treatment, a high BMI was found to improve overall survival.

Surgery Lowers RCC-Related Mortality

By

Partial or radical nephrectomy improves patients' survival odds, data show.

RCC Incidence Higher Among Dialysis Patients

By

Biopsy-proven renal cell carcinoma developed in 35 (0.5%) of 6,827 ESRD patients.

Three Biomarkers Accurately Detect Kidney Cancer

Three Biomarkers Accurately Detect Kidney Cancer

Levels of three serum proteins much higher in kidney cancer patients

Nephron-Sparing Treatments Underused in CKD Patients

By

CKD patients with small renal tumors are nearly two times more likely than those without CKD to under radical nephrectomy.

Women Less Likely to Die from Kidney Cancer

By

The survival advantage over men is greatest among women younger than 42 years.

Dual CKD Risk Factors Prompt Greater Nephron-Sparing Surgery Use

By

Kidney cancer patients with both hypertension and diabetes are twice as likely to undergo nephron-sparing surgery as those with neither condition.

Everolimus May Help Shrink Kidney Tumors in TSC Patients

By

A new international study has found that everolimus may help successfully shrink AMLs in patients with TSC.

Kidney Cancer Linked to Acetaminophen, Nonaspirin NSAIDs

By

Researchers performed a meta-analysis of data from 20 studies that included 8,420 cases of kidney cancer.

Immediate treatment vs. active surveillance of low-risk renal tumors

An important controversy in urologic surgery is immediate treatment versus active surveillance for small, low-risk kidney tumors.

Partial Nephrectomy Prolongs Survival in Younger Patients

By

The 10-year overall survival rate was 94% for partial nephrectomy compared with 89.7% for radical nephrectomy in patients aged 20-44.

Survival Rates Unchanged for Patients with Advanced RCC

By

Relative survival rates for patients with advanced renal cell carcinoma have not improved significantly in the era of targeted agents.

Drugs for Metastatic Kidney Cancer Offer Similar Survival

By

Final overall survival data from a phase 3 trial reveal no significant difference between tivozanib and sorafenib.